News | May 19, 2023
Takeda to strengthen health system for rare diseases in India
These initiatives aim to improve access to healthcare for rare disease patients
These initiatives aim to improve access to healthcare for rare disease patients
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
Farxiga is expected to have such a strong influence on the market due to the impressive results
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023
Sunrise is built on four elements i.e., Awareness, Screening & Diagnosis, Treatment, and Maintenance Support
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
Launches Thalassemia Bal Sewa Yojana portal and releases standard treatment guidelines for sickle cell anemia disease
APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Subscribe To Our Newsletter & Stay Updated
